Compound Monograph

Gallic acid

Gallic acid is a small trihydroxybenzoic (phenolic) acid and the building block of the gallotannins — a well-characterised dietary antioxidant with promising but still largely preclinical metabolic and gastroprotective activity, and rapid, low-bioavailability pharmacokinetics.

Classification

Gallic acid is a hydroxybenzoic acid (phenolic acid), part of the phenolics class. Antioxidant compounds built around one or more phenol rings — the flavonoids, tannins, phenolic acids, coumarins, and pigments behind much of a plant's protective chemistry.

Where Does It Come From? (16)

Gallic acid is a naturally occurring hydroxybenzoic acid (phenolic acid), found in Arjuna, Bearberry, Cashew and 13 other sources. It is well tolerated orally (low toxicity).

Pharmacology & Research

Gallic acid is a small trihydroxybenzoic acid — a simple phenolic acid that also forms the core unit of the gallotannins (hydrolysable tannins). It is one of the most widely distributed dietary phenolics, abundant in clove, oak galls, black tea, berries and nuts, and it turns up across this database as a member of many herbs’ tannin/phenolic fraction rather than as an isolated drug. Its defining property is antioxidant chemistry — the trihydroxy ring is a potent radical scavenger and metal chelator 4Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study → — but the practical story is shaped by its pharmacokinetics: gallic acid is absorbed and cleared rapidly (plasma half-life ~1 hour) and is extensively converted to weaker metabolites 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →, so most of the striking potency seen in a test tube does not translate to achievable human blood levels. Almost all disease-outcome evidence is preclinical; there is a single verified trial of the isolated molecule.

What the evidence supports
  • One human isolate trial: gallic acid 200 mg/day for 12 weeks produced modest reductions in waist measures and skinfolds in obese subjects — but mainly in the arm that also exercised, so the isolate’s own contribution can’t be separated 1Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →.
  • Strong mechanism, weak translation: a well-substantiated antioxidant and partial-PPARγ/GLUT4 metabolic mechanism 2,4Reference 2Variya BC et al. · 2014Gallic acid attenuates high-fat diet/streptozotocin-induced insulin resistance via partial agonism of PPARγ and GLUT4 translocation through PI3K/p-Akt signallingView study →Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study →, undercut by ~1-hour clearance and low bioavailability 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →.
  • The honest headline: gastroprotective, anticancer and antimicrobial reputations rest on whole-extract or in-vitro work, not on isolated gallic acid.
Evidence by indicationStrength of support
AnticancerUnsupported
18%
AntimicrobialUnsupported
18%
1. Metabolic / body composition

This is the only application with human isolate data. In high-fat-diet/STZ diabetic rats, gallic acid acted as a partial PPARγ agonist and promoted GLUT4 translocation via PI3K/Akt, improving insulin sensitivity 2Reference 2Variya BC et al. · 2014Gallic acid attenuates high-fat diet/streptozotocin-induced insulin resistance via partial agonism of PPARγ and GLUT4 translocation through PI3K/p-Akt signallingView study →, a result echoed with Emblica-derived gallic acid 3Reference 3Nampoothiri SV et al. · 2019Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signallingView study →. A 2026 double-blind RCT then gave gallic acid 200 mg/day for 12 weeks to obese adults with and without physical training: the supplemented-and-trained group showed modest but significant reductions in waist-to-hip ratio, waist circumference and pectoral/abdominal skinfolds, plus a rise in serum albumin 1Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →.

A separate in-vitro thread adds a plausible fat-handling angle: gallic acid inhibits pancreatic lipase through hydrogen-bonding and hydrophobic interaction, a rationale for modulating dietary-fat absorption 11Reference 11Zhang Y et al. · 2022Characterization, antioxidant activities, and pancreatic-lipase inhibitory effect of extract from the edible insect Polyrhachis vicinaView study →.

Gap: the human effects were small and concentrated in the exercise-plus-supplement arm, so gallic acid’s own contribution can’t be isolated; no glycaemic endpoint reached significance for the isolate, the lipase result is purely in-vitro at unknown gut-relevant concentrations, and no stand-alone diabetes RCT exists 1,11Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →Reference 11Zhang Y et al. · 2022Characterization, antioxidant activities, and pancreatic-lipase inhibitory effect of extract from the edible insect Polyrhachis vicinaView study →.

2. Antioxidant (property)

Gallic acid’s trihydroxybenzoic structure makes it a potent direct radical scavenger and transition-metal chelator, and in cell and animal models it also upregulates endogenous antioxidant defences (Nrf2 / SOD / catalase / glutathione) 4,6,7Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study →Reference 6Staszowska-Karkut M · 2020Phenolic composition, mineral content, and beneficial bioactivities of leaf extracts from black currant, raspberry, and aroniaView study →Reference 7Agnihotri VK et al. · 2008Antioxidant constituents of Nymphaea caerulea flowersView study →. This is the best-substantiated property underlying its other proposed uses. The one human antioxidant signal came from volunteers drinking Phyllanthus niruri tea, whose plasma gallic acid rose alongside improved antioxidant status 5Reference 5Colpo AC et al. · 2014Antioxidant effects of Phyllanthus niruri tea on healthy subjectsView study →.

Gap: this is a mechanism, not a clinical outcome; the direct-antioxidant data are in-vitro/animal, the lone human signal used a plant tea rather than the isolate, and rapid conversion to weaker metabolites limits how far it carries in the body 5,12Reference 5Colpo AC et al. · 2014Antioxidant effects of Phyllanthus niruri tea on healthy subjectsView study →Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →.

3. Gastroprotective

Ethanol-induced gastric-lesion models attribute mucosal protection to gallic-acid-containing polyphenol fractions — guarana’s caffeic/gallic/tannic acid content 9Reference 9Basile A et al. · 2005Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana MartView study →, and a Virola elongata stem-bark antiulcer extract in which gallic acid is the standardisation marker 8Reference 8Michelin DC et al. · 2018Chemical characterization and evaluation of gastric antiulcer properties of the hydroethanolic extract of the stem bark of Virola elongataView study →. The presumed mechanism is antioxidant/astringent protection of the mucosa.

Gap: the protected agent is always a whole extract; no controlled study isolates gallic acid as the gastroprotective agent, and there is no human data 8,9Reference 8Michelin DC et al. · 2018Chemical characterization and evaluation of gastric antiulcer properties of the hydroethanolic extract of the stem bark of Virola elongataView study →Reference 9Basile A et al. · 2005Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana MartView study →.

4. Anticancer

Across tumour cell lines, gallic acid induces ROS-dependent apoptosis, caspase activation and cell-cycle arrest, and shows anti-angiogenic and anti-metastatic effects in models 4Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study →.

Gap: entirely in-vitro/animal, and the active concentrations often exceed the ~2 µmol/L plasma level humans actually reach 4,12Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study →Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →. This is not evidence for gallic acid as a cancer therapy.

5. Antimicrobial

Gallic acid contributes to plant-extract activity against food pathogens such as Staphylococcus aureus, Listeria monocytogenes and Salmonella, likely through membrane disruption 9,10Reference 9Basile A et al. · 2005Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana MartView study →Reference 10Prado Martin JG et al. · 2013Antimicrobial activity of yerba mate (Ilex paraguariensis) against food pathogensView study →.

Gap: activity is demonstrated within extracts rather than as a purified monotherapy, with no in-vivo or human infection data 9,10Reference 9Basile A et al. · 2005Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana MartView study →Reference 10Prado Martin JG et al. · 2013Antimicrobial activity of yerba mate (Ilex paraguariensis) against food pathogensView study →.

Mechanisms

Target / pathwayEffectRelevant to
Direct radical scavenging + Fe/Cu chelationneutralises ROS, blocks Fenton chemistryantioxidant (all uses)
Nrf2 / antioxidant-enzyme induction↑ endogenous SOD, catalase, glutathioneantioxidant, gastroprotection
PPARγ partial agonismimproved adipocyte insulin sensitivitymetabolic
GLUT4 translocation via PI3K/Akt↑ muscle glucose uptakemetabolic
Pancreatic lipase inhibition (in vitro)↓ gut triglyceride hydrolysisbody composition
ROS burst → caspase activation, cycle arrestpro-apoptotic in tumour cellsanticancer (preclinical)
Microbial membrane disruptionbacteriostatic within extractsantimicrobial

Pharmacokinetics

Gallic acid’s pharmacokinetics are the decisive caveat. In healthy volunteers given ~50 mg (as supplement or tea), it was absorbed rapidly but eliminated just as fast — mean plasma half-life ≈ 1.1 hours, with Cmax only ~1.8–2.1 µmol/L 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →. It is heavily biotransformed: the dominant circulating metabolite is 4-O-methylgallic acid (COMT-type methylation), alongside pyrogallol from decarboxylation, then phase-II sulfation and glucuronidation, with additional gut-microbial degradation. Free unconjugated gallic acid is therefore short-lived and low, and its main metabolites are weaker antioxidants than the parent — which is why in-vitro potency reads across poorly to human effect 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →.

Clinical trials

There is essentially one verified randomised trial of isolated gallic acid (Barbosa 2026, obesity ± exercise) 1Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →, plus a healthy-volunteer pharmacokinetic study 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study → and a plant-tea biomarker study 5Reference 5Colpo AC et al. · 2014Antioxidant effects of Phyllanthus niruri tea on healthy subjectsView study →. All disease-outcome efficacy (metabolic, gastroprotective, anticancer, antimicrobial) is otherwise rodent, extract-based or in-vitro.

CompletedPlannedTerminatedPreclinical
1isolate RCT (body composition)Extensive

Last checked: July 2026.

Toxicity & Safety

Gallic acid is a ubiquitous dietary phenolic (tea, clove, berries, nuts, red wine) and is regarded as low-toxicity at dietary and studied supplemental doses; the 200 mg/day human trial reported no safety signal 1,4Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →Reference 4Kahkeshani N et al. · 2019ReviewPharmacological effects of gallic acid in health and diseases: a mechanistic reviewView study →. The caveats are largely theoretical and preclinical: like many polyphenols it can turn pro-oxidant at high concentrations (redox cycling that generates hydrogen peroxide), relevant only to supraphysiologic exposure; as a phenolic acid it is a substrate for COMT-type methylation and can compete at CYP and UGT/SULT metabolic routes, so additive or competitive drug-metabolism interactions are plausible but not clinically documented for the isolate; and its mild glucose-lowering action creates a theoretical additive effect with antidiabetic agents. Astringency/tannin cautions properly attach to the tannin-rich whole herbs, not to the purified acid. No verified human interaction or contraindication dataset exists for isolated gallic acid.

Dosage

There is no established therapeutic dose for gallic acid, and the figures here are research doses, not a recommendation. The single human isolate trial used 200 mg/day orally for 12 weeks 1Reference 1Barbosa BK et al. · 2026RCTCombined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical TrialView study →; the pharmacokinetic study used a single ~50 mg dose 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →; rodent metabolic studies typically used ~10–25 mg/kg 2,3Reference 2Variya BC et al. · 2014Gallic acid attenuates high-fat diet/streptozotocin-induced insulin resistance via partial agonism of PPARγ and GLUT4 translocation through PI3K/p-Akt signallingView study →Reference 3Nampoothiri SV et al. · 2019Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signallingView study →, which does not translate directly to humans. Given rapid clearance (half-life ~1 hour), any biological effect likely depends on repeated intake rather than single doses 12Reference 12Shahrzad S et al. · 2001Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humansView study →.

References

  1. Barbosa BK, et al. (2026). Combined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Nutrients. https://pubmed.ncbi.nlm.nih.gov/41599924/
  2. Variya BC, Bakrania AK, Patel SS, et al. (2014). Gallic acid attenuates high-fat diet/streptozotocin-induced insulin resistance via partial agonism of PPARγ and GLUT4 translocation through PI3K/p-Akt signalling. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/25445038/
  3. Nampoothiri SV, et al. (2019). Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signalling. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/31064680/
  4. Kahkeshani N, Farzaei F, Fotouhi M, et al. (2019). Pharmacological effects of gallic acid in health and diseases: a mechanistic review. Iranian Journal of Basic Medical Sciences. https://pubmed.ncbi.nlm.nih.gov/31156781/
  5. Colpo AC, et al. (2014). Antioxidant effects of Phyllanthus niruri tea on healthy subjects. Asian Pacific Journal of Tropical Medicine. https://pubmed.ncbi.nlm.nih.gov/24461523/
  6. Staszowska-Karkut M, Materska M (2020). Phenolic composition, mineral content, and beneficial bioactivities of leaf extracts from black currant, raspberry, and aronia. Nutrients. https://pubmed.ncbi.nlm.nih.gov/32059465/
  7. Agnihotri VK, et al. (2008). Antioxidant constituents of Nymphaea caerulea flowers. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/18534639/
  8. Michelin DC, et al. (2018). Chemical characterization and evaluation of gastric antiulcer properties of the hydroethanolic extract of the stem bark of Virola elongata. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/30415060/
  9. Basile A, et al. (2005). Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/16040216/
  10. Prado Martin JG, et al. (2013). Antimicrobial activity of yerba mate (Ilex paraguariensis) against food pathogens. Revista Argentina de Microbiología. https://pubmed.ncbi.nlm.nih.gov/23876271/
  11. Zhang Y, et al. (2022). Characterization, antioxidant activities, and pancreatic-lipase inhibitory effect of extract from the edible insect Polyrhachis vicina. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/35464030/
  12. Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I (2001). Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/11285327/